P. Ron Ellis, President and CEO at ENDOCYTE INC (ECYT), sold 500 shares at $13.88 ($7K) on 2013-05-01, disclosed to the SEC on 2013-05-03.
Scheduled sale ($7k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ECYT | SELL | 2013-10-02 | $40K | — | Filing → |
| ECYT | SELL | 2013-09-05 | $44K | — | Filing → |
| ECYT | SELL | 2013-08-06 | $54K | — | Filing → |